Amorphous calcium carbonate
Sponsors
Amorphical Ltd., Universal Integrated Corp.
Conditions
Bone Mineral DensityBone Turnover MarkerCalciumCastrate Resistant Prostate Cancer With Bone MetastasisDenosumabDistal Radius FracturesHypoparathyroidismOsteoporosis
Phase 1
A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients
CompletedNCT01815021
Start: 2013-04-30End: 2014-06-30Updated: 2015-03-31
A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures
TerminatedNCT01859468
Start: 2013-06-30End: 2015-02-28Updated: 2016-08-04
Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC
WithdrawnNCT02864784
Start: 2022-06-30End: 2023-12-31Updated: 2024-02-28
Improving Function,Welfare of Late-stage Cancer Subjects by ACC
TerminatedNCT03057314
Start: 2017-06-25End: 2019-12-31Updated: 2024-02-28
Unknown Phase
A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
TerminatedNCT06288490
Start: 2013-04-30End: 2014-06-25Updated: 2024-03-01
A Study of Amorphous Calcium Carbonate in Postmenopausal Women
RecruitingNCT06728462
Start: 2025-03-04End: 2027-03-01Target: 205Updated: 2025-03-07